PSYCHOTHERAPY FOR ADOLESCENTS, CHildren AND ADULTS
A body of remarkable experiments have shown that fungi operate as individuals, engage in decision-making, are capable of learning, and possess short-term memory.
These findings highlight the spectacular sensitivity of such ‘simple’ organisms, and situate the human version of the mind within a spectrum of consciousness that might well span the entire natural world.
Read moreContemplating a psychedelic “trip”?
Here is all you need to know about two of your options: Psilocybin vs. DMT.
Read moreNew research shows that ayahuasca, a psychedelic beverage, modulates neuroplasticity induced by ethanol in mice.
Read moreWearable psychedelics could soon give users maximum control over their trip.
Scientists are working on a pharmaceutical device to help give people the best possible experiences on the likes of DMT and LSD.
Read moreHere’s the latest on how there is a shift in psychiatry toward a new way of thinking about depression, its causes, and therapies.
The profession’s long embrace of the “monoamine hypothesis” — the idea that depression primarily results from abnormal levels of neurotransmitter chemicals in the brain and that drugs can restore the proper balance — is giving way to a more complex understanding and alternative treatments, from ketamine to psychedelics to magnetic stimulation.
Read moreThis study shows that many psychedelic users turn to storytelling to reframe challenging trips into positive experiences.
Read moreRecently, psychedelic drugs have once again taken popular culture by storm.
From the psychedelic startup companies newly forming on Wall Street to a recent New York Timesarticle that claims "psychedelic drugs are closer to medicinal use," it seems that there is a renewed media and medical interest in acid (LSD), mushrooms (psilocybin), ecstasy (MDMA), ayahuasca, DMT (dimethyltryptamine), and ketamine.
Read moreCheck out this podcast— Founder and Executive Director of the Multidisciplinary Association for Psychedelic Studies Rick Doblin discusses the role of MDMA-guided psychotherapy in treating PTSD.
Rick shares the story of how he developed a passion for healing the brain with psychedelics and the 35-year journey he’s endured to build a growing non-profit organization. He also explains how to effectively work with drugs that have been aggressively stigmatized and politicized.
Read moreUpon the FDA approval of psychedelic medicine for psychiatric indications—such as MDMA for post-traumatic stress disorder or psilocybin for depression—psychiatric pharmacists in particular and all pharmacists generally, will play a pivotal role in the psychedelic medicine market in the US.
Read moreResearchers are looking at how to safely administer powerful psychedelics for treating depression and post-traumatic stress disorder.
Read morePsychedelic users say that even bad trips gave them ‘life-altering insights’, a small study finds.
Read more